With just over three weeks left to choose new coverage in the health law marketplaces, deciphering the complex system of subsidies remains a key challenge for many would-be insurance customers.
A WSJ reporter followed a group of families and scientists trying to accelerate the development of a drug to treat Niemann-Pick Type C disease, a rare and fatal cholesterol metabolism disorder known as NPC that strikes primarily children.
For years, Christopher P. Austin has been trying to develop a way for science to build a better partnership with patients. Dr. Austin and the Journal’s Amy Dockser Marcus are answering questions now.